Genmab A/S (GNMSF)
265.27
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Genmab Total Liabilities (Quarterly) : 6.694B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ascendis Pharma A/S | 1.746B |
| Zealand Pharma A/S | 128.29M |
| Bavarian Nordic A/S | 218.01M |
| Bioporto A/S | 4.744M |
| Evaxion AS | 10.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.38B |
| Shareholders Equity (Quarterly) | 5.682B |
| Debt to Equity Ratio | 0.9417 |
| Current Ratio | 2.184 |
| Net Debt Paydown Yield | -6.40% |